[Early clinical results of cocarboxylase in grave human tuberculosis].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D006801:Humans; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D013835:Thiamine Pyrophosphate; D013307:Streptomycin
COCARBOXYLASE/therapeutic use; NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
Prime osservazioni cliniche sugli effetti della cocarbossilasi nella tubercolosi umana grave.